What Is NMN? A guide to nicotinamide mononucleotide

Discover what NMN is & learn how to choose a high-quality NMN supplement with Blackmores’ expert advice.

Nicotinamide mononucleotide (NMN) is one of the most discussed compounds in healthy ageing research. In December 2025, the Therapeutic Goods Administration approved NMN as a permissible ingredient in Australian listed medicines, making Australia the first country globally to formally regulate NMN within a therapeutic framework. The decision followed years of growing scientific interest in how cellular energy pathways shift as we age.

This guide covers what NMN is, how it relates to NAD+, what current research shows, and what to consider before adding it to a wellbeing routine.

What is NMN and how does it relate to NAD+?

NMN, short for β-nicotinamide mononucleotide, is a naturally occurring molecule found in every cell of the human body. It is a metabolite of nicotinamide (a form of vitamin B3) that acts as a direct precursor in the production of NAD+, or nicotinamide adenine dinucleotide.

NMN occurs naturally in foods such as edamame, broccoli, cabbage, avocado, and beef, though only in trace amounts. A 2022 paper in npj Aging measured concentrations at around 1 mg per 100 g of food, meaning dietary intake alone can only provide minimal amounts.

Why NMN is important for cellular energy and function

NMN is involved in the body's NAD+ (nicotinamide adenine dinucleotide) biosynthesis pathways. NAD+ is a naturally occurring molecule found throughout the body, and NMN is one of several precursors the body uses to produce it.

A 2020 review published in Experimental Gerontology described the NAD+ salvage pathway, the body's main route for synthesising NAD+ from its building blocks. NMN sits within this pathway as an intermediate compound.

Research has also explored how NAD+ levels change with age. A 2021 review in Nutrients examined the available data and concluded that while changes in NAD+ have been reported across multiple species, the evidence in humans is still developing, and findings vary considerably between tissues and individuals.

How NMN works in the body

The pathway from NMN to NAD+ is relatively short. After oral ingestion, NMN is absorbed in the gastrointestinal tract and converted to NAD+ through the salvage pathway, the body's main route for recycling NAD+ from its building blocks.

A 2022 study in Frontiers in Nutrition tested 250 mg of oral NMN daily in healthy adults over 12 weeks and reported that supplementation was well tolerated. A separate study in npj Aging involving healthy older men examined 250 mg of NMN daily over 12 weeks and observed potential changes in some markers of muscle function.

Recent research has revealed that gut bacteria play a part in this conversion. 2026 research published in Nature Metabolism found that gut microbes appear to convert orally ingested NMN and NR into nicotinic acid before it reaches the bloodstream, where it then contributes to NAD+ synthesis. This adds an extra layer to the simple precursor model the field previously assumed.

NMN: what current research suggests

A 2025 review in Food Frontiers examined NMN's effects across animal and human studies. The authors noted that while preclinical studies in rodents have shown promising effects on metabolism, mitochondrial function, and physical performance, the human evidence base is much smaller and outcomes have varied across trials.

A 12 week 2022 study by Nutrients involved 108 older Japanese adults given 250 mg of NMN per day or placebo. The study reported some signals of altered sleep quality and physical performance measures, though results varied by outcome and time of dosing.

Is NMN well tolerated and suitable for daily use?

Human safety data for NMN has grown substantially over the past five years. The 2024 Advances in Nutrition review summarised available human trials and reported that oral NMN was broadly well tolerated, with most reported side effects being mild and temporary, such as gastrointestinal discomfort.

Australian regulatory parameters provide additional clarity. Under the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025, NMN may be used in Australian listed medicines (AUST L) under the following conditions:

• Maximum daily dose of 500 mg
• Oral administration only
• For use in adults
• Not for use during pregnancy or breastfeeding
• Recommended duration of use of 12 weeks or less

These parameters align with the conditions used in the majority of human clinical trials. They also reflect current gaps in long term safety data, particularly for use beyond 12 weeks and in specific populations.

If you take prescription medications, manage a chronic health condition, or are planning surgery, speak with your healthcare professional before starting NMN.

What to consider when choosing an NMN supplement

The Australian NMN market is new and product quality varies. A few factors are worth checking before purchasing.

Look for an AUST L number

In Australia, listed medicines carry an AUST L number on the label. This indicates the product has been registered with the TGA and complies with quality, manufacturing, and ingredient standards for listed complementary medicines. Products without an AUST L number that make NMN claims may sit outside Australian regulatory oversight.

Check the dose and form

Most clinical studies have used doses between 250 mg and 500 mg per day, with research durations typically running from 8 to 12 weeks. The TGA caps daily doses in Australian listed medicines at 500 mg. Products advertising higher doses may exceed permitted limits or fall outside the regulated framework.

Consider purity and stability

NMN can degrade into nicotinamide during manufacturing or storage if not handled correctly. Reputable brands publish purity data and use packaging that protects the ingredient from heat and moisture. The TGA's NMN compositional guideline now defines specific identity, assay range, and impurity criteria for the Australian market.

Place it in context

Lifestyle foundations that include regular movement, adequate sleep, balanced nutrition, and stress management remain the interventions with the strongest long-term evidence for healthy ageing. Our guide to habits for healthy ageing covers these foundations in more detail. Blackmores Cellular Energy NMN, where available in the local market, is formulated in line with the TGA's compositional requirements for permitted NMN in listed medicines and sits within a broader range of products developed for healthy ageing.

Key takeaways: understanding NMN in a modern wellness context

NMN is a natural precursor to NAD+ and is involved in NAD+ biosynthesis pathways in the body. Human research has examined oral NMN supplementation at studied doses of 250 to 500 mg per day, with most trials running between 8 and 12 weeks. The broader relationship between NMN supplementation and healthy ageing outcomes is still being investigated, and the human evidence base continues to develop.

Australian consumers have unusually clear regulatory ground to stand on. The TGA's December 2025 inclusion of NMN as a permissible ingredient sets defined safety, dosage, and quality parameters for the local market, and the Australian framework remains the most rigorous globally.

For those interested in NMN, the sensible approach is to view it as one possible input within a broader, evidence-based approach to healthy ageing, alongside lifestyle foundations and informed product selection.

Always read the label and follow the directions for use.

Disclaimer: This article provides general information only and is not intended to diagnose, treat, cure, or prevent any disease. The information presented is not a substitute for professional medical advice. If you have concerns about your health, please consult your GP or healthcare provider for a personalised assessment and recommendations. Supplements should not replace a balanced diet.